Stay updated on Mepolizumab Clinical Trial for HES & Severe Asthma

Sign up to get notified when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.
Latest website image capture
Clouds background image

Latest updates to the Mepolizumab Clinical Trial for HES & Severe Asthma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page revision tag updated from v3.4.2 to v3.4.3. This reflects a minor metadata/version update and does not change the study content or its parameters.
    Difference
    0.1%
    Check dated 2026-03-06T19:03:02.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Footer/site revision updated from v3.4.1 to v3.4.2; no changes to study content or expected user actions—To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:37:06.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 on the page. This appears to be a backend/metadata update with no impact on study details or user-facing features.
    Difference
    0.1%
    Check dated 2026-02-05T15:15:18.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC-related metadata, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; older variants and different capitalization (e.g., 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data') were removed or reformatted.
    Difference
    0.3%
    Check dated 2026-01-29T06:27:25.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-15T02:48:09.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link has been removed and Revision: v3.3.2 was deleted.
    Difference
    0.1%
    Check dated 2025-12-24T11:48:57.000Z thumbnail image

Stay in the know with updates to Mepolizumab Clinical Trial for HES & Severe Asthma

Enter your email address, and we'll notify you when there's something new on the Mepolizumab Clinical Trial for HES & Severe Asthma page.